Clinical Trials Directory

Trials / Completed

CompletedNCT00206830

SHORTness of Breath In the Emergency Department (SHORTIE)

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
306 (planned)
Sponsor
Abbott RDx Cardiometabolic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

SHORTIE is a two-phase study to determine the impact of the Triage Profiler S.O.B. (Shortness Of Breath) Panel on patient management, outcome, and cost.

Detailed description

Patients presenting to the ED with a primary complaint of shortness of breath will a have blood sample collected at enrollment and tested using the Triage® Profiler S.O.B. Panel (measuring creatine kinase MB \[CK-MB\], myoglobin, troponin I, B-type natriuretic peptide \[BNP\], D-dimer). The test is used as an aid in the diagnosis of myocardial infarction (MI), an aid in the diagnosis and assessment of severity of heart failure (HF), and an aid in the assessment and evaluation of disseminated intravascular coagulation including pulmonary embolism (PE). Phase I is an observational study and results of the Triage Profiler S.O.B. panel will be blinded to all attending physicians and health care workers. In Phase II, patients will be assigned to either the experimental arm or the control arm of the study. In the experimental arm, the Triage Profiler S.O.B. Panel results will be available to the treating physician and can be incorporated into the decision making process. In the control arm, treating physicians and staff will be blinded to the Triage Profiler S.O.B. Panel results. Time to appropriate treatment, length of ED stay, patient outcome and hospital costs will be assessed in all patients and used to determine the impact of Triage Profiler S.O.B Panel on these parameters. Furthermore, the diagnostic accuracy of the Triage Profiler S.O.B Panel will be calculated.

Conditions

Interventions

TypeNameDescription
DEVICETriage Profiler S.O.B. Panel

Timeline

Start date
2005-04-01
Primary completion
2006-08-01
Completion
2007-08-01
First posted
2005-09-21
Last updated
2015-07-27

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00206830. Inclusion in this directory is not an endorsement.